Literature DB >> 10680740

Seroprevalence of viral childhood infections in Eritrea.

T Tolfvenstam1, M Enbom, H Ghebrekidan, U Rudén, A Linde, M Grandien, B Wahren.   

Abstract

BACKGROUND: The seroprevalence of viral childhood infections in Africa has not been thoroughly investigated. The relatively recently discovered human parvovirus B19 (B19) and human herpesvirus 6 (HHV-6) have received particularly little attention.
OBJECTIVE: To investigate the seroprevalence of viral childhood infections in different Eritrean populations and to define groups at high risk for infection. STUDY
DESIGN: Five population groups in Eritrea have been examined to define the prevalence of specific antibodies to several childhood viruses. The study population of more than 400 persons consisted of children, pregnant women, female sex workers and members of a secluded tribe called Rashaida.
RESULTS: All groups showed a high prevalence of antibodies to measles and HHV-6 (> 85%). For rubella, the seroprevalence was very high in all adult groups (93-99%) except the Rashaida group (71%). The mumps prevalence was surprisingly low in the Rashaida group (29%) compared to 46-85% in the other adults. Late encounter of mumps and rubella was also observed among the Rashaidas. The pattern of antibodies to B19 showed a higher seroprevalence in all groups (56-91%) compared to what has been reported from the western world.
CONCLUSION: The findings represent what might be expected in an unvaccinated population. The exception was the Rashaidas, which had low seroprevalences and late encounter of mumps and rubella. This is of importance because it makes this tribe vulnerable to these infections, which are associated with complications when acquired in adult age. Also noteworthy is the high frequency of antibodies to HHV-6 and particularly B19 in all groups, indicative of an early encounter of both these viruses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10680740     DOI: 10.1016/s1386-6532(99)00070-0

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  14 in total

Review 1.  Parvovirus B19 infection in human pregnancy.

Authors:  R F Lamont; J D Sobel; E Vaisbuch; J P Kusanovic; S Mazaki-Tovi; S K Kim; N Uldbjerg; R Romero
Journal:  BJOG       Date:  2010-10-13       Impact factor: 6.531

2.  Evidence of serological cross-reactivity between genotype 1 and genotype 3 erythrovirus infections.

Authors:  Amanda Corcoran; Sean Doyle; Jean-Pierre Allain; Daniel Candotti; Armen Parsyan
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

Review 3.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

4.  Identification and characterization of persistent human erythrovirus infection in blood donor samples.

Authors:  Daniel Candotti; Nermin Etiz; Armen Parsyan; Jean-Pierre Allain
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

Review 5.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

6.  Parvovirus B19 infection and severe anaemia in Kenyan children: a retrospective case control study.

Authors:  James Wildig; Yvonne Cossart; Norbert Peshu; Nimmo Gicheru; James Tuju; Thomas N Williams; Charles R Newton
Journal:  BMC Infect Dis       Date:  2010-04-03       Impact factor: 3.090

7.  A review of data needed to parameterize a dynamic model of measles in developing countries.

Authors:  Emily K Szusz; Louis P Garrison; Chris T Bauch
Journal:  BMC Res Notes       Date:  2010-03-16

8.  Chloroquine and its derivatives exacerbate B19V-associated anemia by promoting viral replication.

Authors:  Claudia Bönsch; Christoph Kempf; Ivo Mueller; Laurens Manning; Moses Laman; Timothy M E Davis; Carlos Ros
Journal:  PLoS Negl Trop Dis       Date:  2010-04-27

9.  Parvovirus B19V infection in Israel: prevalence and occurrence of acute infection between 2008 and 2013.

Authors:  O Mor; I Ofir; R Pavel; R Bassal; Z Kra-Oz; D Cohen; T Shohat; E Mendelson
Journal:  Epidemiol Infect       Date:  2015-05-20       Impact factor: 4.434

10.  The seroprevalence of parvovirus B19 infection in pregnant women in Sudan.

Authors:  O Adam; T Makkawi; U Reber; H Kirberg; A M Eis-Hübinger
Journal:  Epidemiol Infect       Date:  2014-03-20       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.